Related Experiment Video
Updated: Dec 30, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Oncogenic Role of an Epigenetic Reader of m6A RNA Modification: YTHDF1 in Merkel Cell Carcinoma
Elias Orouji1,2,3, Wiebke K Peitsch2,4, Azadeh Orouji2
1Skin Cancer Unit, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Abstract:
Merkel cell carcinoma is a deadly skin cancer, which in the majority of cases is caused by the Merkel cell polyomavirus (MCPyV). The viral small T antigen is regarded as the dominant oncoprotein expressed in the tumor cells. We used genomic screening of copy number aberrations along with transcriptomic analysis to investigate regions with amplification that harbor differentially expressed genes. We identified YTHDF1, a protein that is a reader of N6-methyladenosine (m6A) RNA modifications, to have high copy gains and to be highly expressed in Merkel cell carcinoma. Importantly, we identified the presence of m6A on small T antigen mRNA suggesting a relation between YTHDF1 amplification and MCPyV gene expression. Interestingly, knockdown of YTHDF1 in Merkel cell carcinoma (MCC) cell lines negatively affected the translation initiation factor eIF3 and reduced proliferation and clonogenic capacity in vitro. Furthermore, analysis of survival data revealed worse overall survival in YTHDF1high MCC patients compared to YTHDF1low patients. Our findings indicate a novel oncogenic role of YTHDF1 through m6A machinery in the tumorigenesis of MCC.
Insights
Merkel cell carcinoma (MCC) is linked to the Merkel cell polyomavirus (MCPyV). YTHDF1, involved in RNA modifications, is amplified in MCC and may drive tumor growth by affecting viral gene expression and cell proliferation.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Merkel cell carcinoma (MCC) is an aggressive skin cancer often caused by the Merkel cell polyomavirus (MCPyV).
- The viral small T antigen is a key oncoprotein in MCC development.
- Understanding the molecular mechanisms driving MCC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate genetic alterations and gene expression patterns in MCC.
- To identify novel oncogenic drivers and their role in MCPyV-driven tumorigenesis.
- To explore the function of YTHDF1, an m6A reader, in MCC development.
Main Methods:
- Genomic screening for copy number aberrations and transcriptomic analysis.
- Analysis of YTHDF1 expression and its correlation with MCPyV oncoprotein.
- In vitro knockdown experiments in MCC cell lines to assess YTHDF1 function.
- Correlation of YTHDF1 expression with patient survival data.
Main Results:
- YTHDF1 exhibits high copy gains and expression in MCC.
- YTHDF1 interacts with m6A modification on MCPyV small T antigen mRNA.
- YTHDF1 knockdown reduces MCC cell proliferation and clonogenic capacity.
- High YTHDF1 expression correlates with worse patient survival in MCC.
Conclusions:
- YTHDF1 plays a significant oncogenic role in MCC tumorigenesis.
- The YTHDF1-m6A pathway is a potential therapeutic target for MCC.
- YTHDF1 amplification contributes to MCPyV-driven cancer development.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Spreading of Chromatin Modifications
Writers
The writer...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

